Your Good Partner in Biology Research

  1. Home
  2. 抗体
  3. 多克隆抗体
  4. NLRP1 Antibody

NLRP1 Antibody

  • 货号：
    CSB-PA871630EA01HU
  • 规格：
    ￥440
  • 促销：
    小规格抗体限时一口价
  • 图片：
    • Immunofluorescence staining of SH-SY5Y cells with CSB-PA871630EA01HU at 1:133, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
  • 其他：

产品详情

  • 产品名称：
    Rabbit anti-Homo sapiens (Human) NLRP1 Polyclonal antibody
  • Uniprot No.：
    Q9C000
  • 基因名：
  • 别名：
    CARD 7 antibody; CARD7 antibody; Caspase recruitment domain protein 7 antibody; Caspase recruitment domain-containing protein 7 antibody; CLR17.1 antibody; Death effector filament forming Ced 4 like apoptosis protein antibody; Death effector filament-forming ced-4-like apoptosis protein antibody; DEFCAP antibody; DEFCAP L/S antibody; DKFZp586O1822 antibody; KIAA0926 antibody; LRR and PYD domains-containing protein 1 antibody; NAC alpha/beta/gamma/delta antibody; NAC antibody; NACHT antibody; NACHT leucine rich repeat and PYD containing 1 antibody; NACHT leucine rich repeat and PYD pyrin domain containing 1 antibody; NACHT leucine rich repeat and pyrin domain containing 1 antibody; NACHT LRR and PYD containing protein 1 antibody; NALP 1 antibody; NALP1 antibody; NALP1_HUMAN antibody; NLR family pyrin domain containing 1 antibody; NLRP 1 antibody; NLRP1 antibody; NLRP1 protein antibody; Nucleotide binding domain and caspase recruitment domain antibody; Nucleotide binding oligomerization domain leucine rich repeat and pyrin domain containing 1 antibody; Nucleotide-binding domain and caspase recruitment domain antibody; PP 1044 antibody; PP1044 antibody
  • 宿主：
    Rabbit
  • 反应种属：
    Human
  • 免疫原：
    Recombinant Human NACHT, LRR and PYD domains-containing protein 1 protein (1-146AA)
  • 免疫原种属：
    Homo sapiens (Human)
  • 标记方式：
    Non-conjugated

    本页面中的产品，NLRP1 Antibody (CSB-PA871630EA01HU)，的标记方式是Non-conjugated。对于NLRP1 Antibody，我们还提供其他标记。见下表：

    可提供标记
    标记方式 货号 产品名称 应用
    HRP CSB-PA871630EB01HU NLRP1 Antibody, HRP conjugated ELISA
    FITC CSB-PA871630EC01HU NLRP1 Antibody, FITC conjugated
    Biotin CSB-PA871630ED01HU NLRP1 Antibody, Biotin conjugated ELISA
  • 克隆类型：
    Polyclonal
  • 抗体亚型：
    IgG
  • 纯化方式：
    >95%, Protein G purified
  • 浓度：
    It differs from different batches. Please contact us to confirm it.
  • 保存缓冲液：
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
  • 产品提供形式：
    Liquid
  • 应用范围：
    ELISA, IF
  • 推荐稀释比：
    Application Recommended Dilution
    IF 1:50-1:200
  • Protocols：
  • 储存条件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 货期：
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

产品评价

靶点详情

  • 功能：
    Acts as the sensor component of the NLRP1 inflammasome, which mediates inflammasome activation in response to various pathogen-associated signals, leading to subsequent pyroptosis. Inflammasomes are supramolecular complexes that assemble in the cytosol in response to pathogens and other damage-associated signals and play critical roles in innate immunity and inflammation. Acts as a recognition receptor (PRR): recognizes specific pathogens and other damage-associated signals, such as cleavage by human rhinoviruses 14 and 16 (HRV-14 and HRV-16), double-stranded RNA or Val-boroPro inhibitor, and mediates the formation of the inflammasome polymeric complex composed of NLRP1, CASP1 and PYCARD/ASC. In response to pathogen-associated signals, the N-terminal part of NLRP1 is degraded by the proteasome, releasing the cleaved C-terminal part of the protein (NACHT, LRR and PYD domains-containing protein 1, C-terminus), which polymerizes and associates with PYCARD/ASC to initiate the formation of the inflammasome complex: the NLRP1 inflammasome recruits pro-caspase-1 (proCASP1) and promotes caspase-1 (CASP1) activation, which subsequently cleaves and activates inflammatory cytokines IL1B and IL18 and gasdermin-D (GSDMD), leading to pyroptosis. Activation of NLRP1 inflammasome is also required for HMGB1 secretion; the active cytokines and HMGB1 stimulate inflammatory responses. Binds ATP and shows ATPase activity. Plays an important role in antiviral immunity and inflammation in the human airway epithelium. Specifically recognizes a number of pathogen-associated signals: upon infection by human rhinoviruses 14 and 16 (HRV-14 and HRV-16), NLRP1 is cleaved and activated which triggers NLRP1-dependent inflammasome activation and IL18 secretion. Positive-strand RNA viruses such as. Semliki forest virus and long dsRNA activate the NLRP1 inflammasome, triggering IL1B release in a NLRP1-dependent fashion. Acts as a direct sensor for long dsRNA and thus RNA virus infection. May also be activated by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, in a NOD2-dependent manner.; Constitutes the precusor of the NLRP1 inflammasome, which mediates autoproteolytic processing within the FIIND domain to generate the N-terminal and C-terminal parts, which are associated non-covalently in absence of pathogens and other damage-associated signals.; Regulatory part that prevents formation of the NLRP1 inflammasome: in absence of pathogens and other damage-associated signals, interacts with the C-terminal part of NLRP1 (NACHT, LRR and PYD domains-containing protein 1, C-terminus), preventing activation of the NLRP1 inflammasome. In response to pathogen-associated signals, this part is ubiquitinated and degraded by the proteasome, releasing the cleaved C-terminal part of the protein, which polymerizes and forms the NLRP1 inflammasome.; Constitutes the active part of the NLRP1 inflammasome. In absence of pathogens and other damage-associated signals, interacts with the N-terminal part of NLRP1 (NACHT, LRR and PYD domains-containing protein 1, N-terminus), preventing activation of the NLRP1 inflammasome. In response to pathogen-associated signals, the N-terminal part of NLRP1 is degraded by the proteasome, releasing this form, which polymerizes and associates with PYCARD/ASC to form of the NLRP1 inflammasome complex: the NLRP1 inflammasome complex then directly recruits pro-caspase-1 (proCASP1) and promotes caspase-1 (CASP1) activation, leading to gasdermin-D (GSDMD) cleavage and subsequent pyroptosis.; It is unclear whether is involved in inflammasome formation. It is not cleaved within the FIIND domain, does not assemble into specks, nor promote IL1B release. However, in an vitro cell-free system, it has been shown to be activated by MDP.
  • 基因功能参考文献：
    1. not associated with obesity in this study PMID: 28634744
    2. eight single nucleotide polymorphisms, four from NLRP1 (rs8079034, rs11651270, rs11657747, and rs878329) and NLRP3 (rs7512998, rs3806265, rs10754557, and rs10733113) each in 540 patients with Psoriasis Vulgaris and 612 healthy controls in the Chinese Han population, were genotyped. PMID: 29850521
    3. the analysis of multiple sclerosis (MS) patients from Canada failed to identify potentially pathogenic mutations in NLRP1, including the previously described p.G587S mutation. Further studies are necessary to confirm a role of NLRP1 in the pathophysiology of MS. PMID: 28988323
    4. Suggest inflammasome protein NLRP1 appears to have a specific role in the development of occlusive aortic disease. PMID: 29528779
    5. Based on the data obtained from patients and in vitro cells, we concluded that both NLRP1 and NLRP3 inflammasomes are highly involved in the FLS inflammation and pyroptosis. PMID: 29393464
    6. NLRP1 promotes cell line MCF-7 the proliferation, migration, and invasion through inducing EMT. PMID: 29214170
    7. The CC genotype of NLRP1 rs878329 and TT genotype of PADI4 rs2240340 were associated with Rheumatoid Arthritis susceptibility in Asians. PMID: 28653215
    8. study results suggest variations in the inflammasome, particularly in NLRP1 and CARD11, may be associated with chronic Chagas cardiomyopathy PMID: 29438387
    9. Data show that cyclic stretch activated the nucleotide-binding oligomerization domain-like receptor containing pyrin domain 1 and 3 (NLRP1 and NLRP3) inflammasomes and induced the release of IL-1beta and pyroptosis via a caspase-1-related mechanism in human periodontal ligament cells (HPDLCs). PMID: 27626170
    10. Our study demonstrated the potentially significant role of NLRP1 rs878329 (G>C) in developing susceptibility to the partial seizures in a Chinese Han population PMID: 28503575
    11. mRNA expression levels of NLRP1 and NLRC4 were not altered in chronic hepatitis B patients, suggesting that these genes are not responsible for the impaired immune responses against HBV observed in these patients. PMID: 27750030
    12. NLRP1 senses cellular infection by distinct invasive pathogens. PMID: 28808162
    13. NLRP1 promotes melanoma growth by enhancing inflammasome activation and suppressing apoptotic pathways. PMID: 28263976
    14. Two new mutations in NLRP1 (c.3641C>G, p.Pro1214Arg and c.2176C>T; p.Arg726Trp) were found to cause a new autoinflammatory syndrome, NLRP1-associated autoinflammation with arthritis and dyskeratosis. PMID: 27965258
    15. Th17 micro-milieu via IL-17A regulates NLRP1-dependent CASP5 activity in psoriatic skin autoinflammation. PMID: 28422993
    16. HO-1 inhibited expression of activating transcription factor 4 (ATF4), which is a transcription factor regulating NLRP1 expression PMID: 26925775
    17. Simvastatin intake in peripheral arterial disease patients increases in vitro reactivity of NLRP1 inflammasome gene expression in endothelial cells. PMID: 27423725
    18. these findings establish a group of non-fever inflammasome disorders, uncover an unexpected auto-inhibitory function for the pyrin domain, and provide the first genetic evidence linking NLRP1 to skin inflammatory syndromes and skin cancer predisposition. PMID: 27662089
    19. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease PMID: 26939933
    20. NLRP1 inflammasome is activated by extracellular acidosis through ASIC1a signal pathway. PMID: 26715049
    21. Nlrp1 inflammasome is downregulated in trauma patients PMID: 26232934
    22. Human central Nervous System neurons express NLRP1 inflammasomes, which activate Casp1 and subsequently Casp6. Casp1 activation generates interleukin-1-beta-mediated neuroinflammation and Casp6 activation causes axonal degeneration. PMID: 25744023
    23. The data of this study suggested that NLRP1/caspase-1 signaling participates in the seizure-induced degenerative process in humans. PMID: 25626361
    24. The NLRP1 variant rs12150220 (L155H) was associated with the development of preeclampsia (OR = 1.58), suggesting a role of this inflammasome receptor in the pathogenesis of this multifactorial disorder. PMID: 25556596
    25. Elevated expression of NLRP1 was associated with pemphigus vulgaris disease progression. PMID: 25342284
    26. Ethanol-induced HMGB1 release is associated with NOX2/NLRP1 inflammasome signaling, which represents a novel mechanism of ethanol-associated neuron injury. PMID: 26079697
    27. NALP1 is expressed low in colon cancer and associated with the survival and tumor metastasis of patients, and treatment with 5-aza-2-deoxycytidine can restore NALP1 levels to suppress the growth of colon cancer. PMID: 25611377
    28. Our data support the involvement of NLRP1 and the NLRP1 inflammasome in psoriasis susceptibility and further support the role of innate immunity in psoriasis. PMID: 24909542
    29. these data identify NLRP1 as an essential mediator of the host immune response during IBD and cancer. PMID: 25725098
    30. Letter: aspirin intake in peripheral arterial disease attenuates NLRP1 inflammasome gene expression in endothelial cells. PMID: 25814374
    31. Inflammatory plasma factors induce NLRP1 on endothelial cells in peripheral artery disease. PMID: 24439873
    32. The NOD-like receptor NLRP1a/Caspase-1 pathway is the best candidate to mediate the parasite-induced cell death. PMID: 24699513
    33. The crystal structure of the LRR domain of human NLRP1 in the absence of muramyl dipeptide. PMID: 25064844
    34. These results indicated deregulation of NLRP3/NLRP1 inflammasomes in patients with systemic lupus erythematosus, and suggested an important role for inflammasomes in the pathogenesis and progression of systemic lupus erythematosus. PMID: 24334646
    35. Results show that polymorphisms in NLRP1 may be risk factors for susceptibility and progression of vitiligo.The upregulation of NLRP1 mRNA in patients with susceptible genotypes advocates the crucial role of NLRP1 in vitiligo. PMID: 23773036
    36. TNF-alpha rs1800629 A/G, NLRP1 rs878329 C/G and NLRP1 rs6502867 C/T polymorphisms were not associated with risk of RA or AS. PMID: 24065540
    37. Studied NLRP1 haplotypes associated with leprosy in Brazilian patients. PMID: 23770116
    38. the NLRP1 and NLRP3 inflammasomes have a major role in neuronal cell death and behavioral deficits in stroke. PMID: 24008734
    39. Stimulation with TNF-alpha is sufficient for activation of the NALP1 inflammasome. PMID: 23940760
    40. The charge surface of the NLRP1 CARD structure and a procaspase-1 CARD model suggests potential mechanisms for their association through electrostatic attraction. PMID: 23508996
    41. Genetic variation in the inflammasome affects atopic dermatitis susceptibility. PMID: 23563199
    42. study found that NLRP1 rs12150220 T allele and NLRP1 rs2670660 G allele were significantly associated with autoimmune thyroid disorders compared with controls; NLRP1 may be involved in the pathogenesis of autoimmune thyroid disorders PMID: 23374100
    43. Our results do not support the role of the NLRP1 rs8182352 in systemic sclerosis. PMID: 23380025
    44. We describe a new corneal intraepithelial dyskeratosis and how we identified its causative gene - NLRP1 PMID: 23349227
    45. NLRP1 shows a genetic association with giant cell arteritis. PMID: 23253924
    46. NLRP1 RNA and protein levels were not altered by the predominant high-risk haplotype, indicating that altered function of the corresponding multivariant NLRP1 polypeptide predisposes to autoimmune diseases by activation of the NLRP1 inflammasome PMID: 23382179
    47. we performed a genetic association study in patients with pneumococcal meningitis and found that single-nucleotide polymorphisms in the inflammasome genes CARD8 and NLRP1 are associated with poor disease outcome. PMID: 23053059
    48. A haplotype, T-T-C-G-A-C, in the NLRP1 gene was associated with a higher risk for Kawasaki disease development. PMID: 22507623
    49. These findings provide evidence of an association between single nucleotide variations in the NLRP1 gene and Alzheimer disease PMID: 21946017
    50. Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity. PMID: 22665479

    显示更多

    收起更多

  • 相关疾病：
    Vitiligo-associated multiple autoimmune disease 1 (VAMAS1); Palmoplantar carcinoma, multiple self-healing (MSPC); Autoinflammation with arthritis and dyskeratosis (AIADK)
  • 亚细胞定位：
    Cytoplasm, cytosol. Cytoplasm. Nucleus.; [NACHT, LRR and PYD domains-containing protein 1, C-terminus]: Inflammasome.
  • 蛋白家族：
    NLRP family
  • 组织特异性：
    Widely expressed. Abundantly expressed in primary immune cells (isoform 1 and isoform 2), including in neutrophils, monocytes/macrophages, dendritic cells (mostly Langerhans cells), and B- and T-lymphocytes (at protein level). Strongly expressed in epithe
  • 数据库链接：

    HGNC: 14374

    OMIM: 606579

    KEGG: hsa:22861

    STRING: 9606.ENSP00000460475

    UniGene: Hs.652273